‘Baraclude’ falls, Lipitor and Viread form two-way strong trend
In the outpatient prescription market, ‘Lipitor(Pfizer)’ and ‘Viread(Gilead Sciences Korea)’ formed the 2-way strong trend.
The BMS Korea’s product which had exclusively led the market for the past years, ‘Baraclude’ has constantly fell down without hope, caused by emergence of strong competito...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
